Berkshire shares suffer longest losing streak in more than 7 years

Berkshire shares have fallen for eight straight sessions (longest streak since Dec 2018), with BRK.A at $703,700 and BRK.B down ~4.7–4.9% over the streak and the S&P off ~5.2% in the same period; Berkshire is down >13% since Buffett signaled his 2025 CEO exit. Berkshire's National Indemnity paid $1.8B for ~2.5% of Tokio Marine (now worth ~ $2.3B), sending Tokio Marine shares up >24% and establishing a strategic reinsurance partnership; Berkshire may raise its stake to just under 10% via open-market buys. Company metrics: market cap ~$1.011T, cash ~$373.3B (Dec 31), and Berkshire resumed buybacks on March 4, 2026 — factors that support capital flexibility despite recent stock weakness.

Analysis

The recent price pressure looks more like a liquidity-led derating than a fundamental shock to operating cash generation — flows from risk-parity, CTAs and retail de-risking are compounding headline-driven selling. That creates a near-term window (days–weeks) where buybacks or visible insider-directed purchases can produce outsized positive reversals because the market impact function of concentrated repurchases is non-linear when sentiment is brittle.

The strategic tie-up with a top-tier Japanese insurer should be valued as an asymmetric optionality instrument rather than a pure stake: it grants deal-sourcing, reinsurance capacity and a regulated runway to scale ownership via open-market purchases, which behaves like a call option on cross-border M&A and underwriting upside over 12–36 months. A successful execution could materially re-rate Berkshire’s non-US earnings mix and accelerate redeployment of float into higher-return opportunities, with spillovers to Japanese financials and trade-oriented conglomerates.

Primary tail risks are geopolitical shock leading to correlated equity drawdowns, a large underwriting loss that forces capital redeployment, or visible execution hiccups under new leadership that sap confidence for multiple quarters. Reversal triggers to watch are (1) a sustained uptick in open-market repurchases disclosed over multiple weeks, (2) a material acceleration of underwriting profitability in reinsurance corridors, or (3) institutional re-weighting back into value/compounders — expect any of these to play out on a 3–12 month cadence and to compress implied downside substantially.

Key Decisions for Investors

• Long BRK.B (core position) — accumulate size in 2–4 tranches over the next 4–8 weeks on continued macro weakness; target +12–18% total return in 6–12 months if repurchases accelerate, set tactical stop-loss at -8% from entry to cap event risk.
• Pair trade: Long BRK.B / Short SPY (dollar neutral) — 6-month horizon to isolate Berkshire-specific alpha from market moves; target BRK to outperform by 5–8%, stop if relative underperformance exceeds 5%.
• Options: Buy a 9–12 month BRK.B call spread (buy near-the-money, sell 25–35% OTM) to capture upside from repurchase visibility with defined max loss (premium) — aim for 2.5–4x payoff if catalysts materialize.
• Thematic: Allocate a small tactical sleeve (2–3% portfolio) to Japanese insurance/reinsurance equities or a Japan financials ETF as a levered play on cross-border underwriting and M&A optionality; time horizon 12–36 months, monitor FX and regulatory headlines closely.